Global Biologics and Biosimilars Market Analysis 2015-2019 and Forecast 2020-2025

ReportPage
Report ID
73668
Published Date
09-Jan
No of Report Page
111
Report Category
Life Sciences
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details

    Snapshot
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimil

    More...
  • Table Of Content

    Table of Content

    1 Industry Overview
    1.1 Biologics and Biosimilars Industry
    Figure Biologics and Biosimilars Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of Biologics and Biosimilars
    1.2 Market Segment
    1.2.1 Upstream
    Table Upstream Segment of Biologics and Biosimilars
    1.2.2 Downstream
    Table Applic

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample